Identification of genetic/genomic factors contributing to dyslipidemia is of great interest to prevention and reduction of the onset and burden of cardiovascular diseases in Africa. This systematic review summarizes available data on genetic variants associated with dyslipidemia in populations within Africa. A PubMed and EMBASE database search was conducted to identify all studies published until June 2018 on genetic susceptibility to dyslipidemia in African-based populations, excluding familial hypercholesterolemia. All studies on genetic predispositions of dyslipidemia and respecting the preestablished inclusion criteria were included in this systematic review. Because of high heterogeneity, the data were summarized narratively. Twenty-two studies investigated mostly the targeted genetic variants. A total of 51 polymorphisms in 28 susceptibility genes to dyslipidemia have been associated with a particular trait in the African populations, and through variable effects. Most polymorphisms investigated in Northern Africa seemed to have consistent effects on increasing the level of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides in patients with diabetes, myocardial infarction, coronary artery disease, and metabolic syndrome. By contrast, only Ser447Ter and C49620T variants were associated with increased LDL-C in sub-Saharan Africa. Despite few studies available in this context in the literature, certain genetic variants were consistently associated with dyslipidemia especially in Northern Africa as highlighted in this analysis. Further data, particularly from genome-wide association studies, would help establish an African-specific reference for genetic susceptibility markers of dyslipidemia.
Get full access to this article
View all access options for this article.
References
1.
1000 Genomes Project Consortium, AutonA, BrooksLD, et al. (2015). A global reference for human genetic variation. Nature, 526, 68–74.
2.
Abd El-AzizTA, HusseinYM, MohamedRH, and ShalabySM. (2012). Renin-angiotensin system genes polymorphism in Egyptians with premature coronary artery disease. Gene, 498, 270–275.
3.
Abd El-AzizTA, MohamedRH, and HagrassHA. (2014). Increased risk of premature coronary artery disease in Egyptians with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes polymorphism. J Clin Lipidol, 8, 381–389.
4.
Abd El-AzizTA, MohamedRH, and HashemRM. (2011). Association of lipoprotein lipase and apolipoprotein C-III genes polymorphism with acute myocardial infarction in diabetic patients. Mol Cell Biochem, 354, 141–150.
5.
Abdel GhanySM, SayedAA, El-DeekSEM, et al. (2017). Obesity risk prediction among women of Upper Egypt: The impact of serum vaspin and vaspin rs2236242 gene polymorphism. Gene, 626, 140–148.
6.
Abdel-HamedAR, GhattasMH, MesbahNM, SalehSM, and Abo-ElmattyDM. (2017) Association of interleukin-1A insertion/deletion gene polymorphism and possible high risk factors with non-alcoholic fatty liver disease in Egyptian patients. Arch Physiol Biochem, 123, 330–333.
7.
AdebamowoSN, Tekola-AyeleF, AdeyemoAA, and RotimiCN. (2017) Genomics of cardiometabolic disorders in Sub-Saharan Africa. Public Health Genomics, 20, 9–26.
8.
AsselbergsFW, GuoY, van IperenEP, et al. (2012). Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet, 91, 823–838.
9.
BennouarN, AllamiA, LaraquiA, et al. (2004). Apolipoprotein E and angiotensin-converting enzyme gene polymorphisms as risk factors of coronary disease. Ann Biol Clin (Paris), 62, 295–304.
10.
BhattiGK, BhattiJS, VijayvergiyaR, and SinghB. (2016). Implications of ACE (I/D) gene variants to the genetic susceptibility of coronary artery disease in Asian Indians. Indian J Clin Biochem, 32, 163–170.
11.
BoghdadyA, ArafaUA, SabetEA, SalamaE, El SharawyA, and ElbadryMI. (2016). Association between rs1761667 polymorphism of CD36 gene and risk of coronary atherosclerosis in Egyptian population. Cardiovasc Diagn Ther, 6, 120–130.
12.
ChenZ, XuF, WeiY, LiuF, and QiH. (2012). Angiotensin converting enzyme insertion/deletion polymorphism and risk of pregnancy hypertensive disorders: A meta-analysis. J Renin Angiotensin Aldosterone Syst, 1, 184–195.
13.
DallongevilleJ, Lussier-CacanS, and DavignonJ. (1992). Modulation of plasma triglyceride levels by apo E phenotype: A meta-analysis. J Lipid Res, 33, 447–454.
14.
EllmanN, KeswellD, CollinsM, TootlaM, and GoedeckeJH. (2015). Ethnic differences in the association between lipid metabolism genes and lipid levels in black and white South African women. Atherosclerosis, 240, 311–317.
15.
ElouejS, Belfki-BenaliH, NagaraM, et al. (2016a). Association of rs9939609 polymorphism with metabolic parameters and FTO risk haplotype among tunisian metabolic syndrome. Metab Syndr Relat Disord, 14, 121–128.
16.
ElouejS, NagaraM, AttaouaR, et al. (2016b). Association of genetic variants in the FTO gene with metabolic syndrome: A case-control study in the Tunisian population. J Diabetes Complications, 30, 206–211.
17.
ElouejS, RejebI, AttaouaR, et al. (2016c) Gender-specific associations of genetic variants with metabolic syndrome components in the Tunisian population. Endocr Res, 41, 300–309.
18.
EngwaGA, NwaloFN, ChikezieCC, et al. (2018). Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population. BMC Med Genet, 19, 78.
19.
FekihO, TrikiS, HellaraI, et al. (2014). Can paraoxonase 1 polymorphisms (L55M and Q192 R) protect children with type 1 diabetes against lipid abnormalities?. J Clin Lipidol, 8, 249–255.
20.
FoffaI, MurziM, MarianiM, et al. (2012). Angiotensin-converting enzyme insertion/deletion polymorphism is a risk factor for thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg, 144, 390–395.
21.
FrankAT, ZhaoB, JosePO, AzarKM, FortmannSP, and PalaniappanLP. (2014). racial/ethnic differences in dyslipidaemia patterns. Circulation, 129, 570–579.
22.
GalatiF, ColonnaP, GalatiA, CiardielloC, BozzettiMP, and MassariS. (2014). CETP TaqIB polymorphism, serum lipid levels and risk of atrial fibrillation: A case-control study. J Atr Fibrillation, 6, 964.
23.
GBD 2016 DALYs and HALE Collaborators. (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390, 1260–1344.
24.
HamelinBA, Zakrzewski-JakubiakM, RobitailleNM, BogatyP, LabbéL, and TurgeonJ. (2011). Increased risk of myocardial infarction associated with angiotensin-converting enzyme gene polymorphism is age dependent. J Clin Pharmacol, 51, 1286–1292.
25.
HendersonHE, KasteleinJJ, ZwindermanAH, et al. (1999). Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins. J. Lipid Res, 40, 735–743
26.
HooperAJ, MaraisAD, TanyanyiwaDM, and BurnettJR. (2007). The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population. Atherosclerosis, 193, 445–448.
27.
HuangAQ, HuYH, ZhanSY, et al. (2006). Lipoprotein lipase gene S447X polymorphism modulates the relation between central obesity and serum lipids, a twin study. Int J Obes (Lond), 30, 1693–1701.
28.
HuangY, and MahleyRW. (2014). Apolipoprotein E: Structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases. Neurobiol Dis, 72A, 3–12.
29.
KefiR, HechmiM, DallaliH, et al. (2017). Association of apolipoprotein A5 gene variants with metabolic syndrome in Tunisian population. Ann Endocrinol, 78, 146–155.
30.
KhellaMS, HamdyNM, AminAI, and El-MesallamyHO. (2017). The (FTO) gene polymorphism is associated with metabolic syndrome risk in Egyptian females: A case- control study. BMC Med Genet, 18, 101.
31.
KodogoV, ZhouDT, OektedalenO, DuriK, Stray-PedersenB, and GomoE. (2016). Apolipoprotein B gene polymorphisms and dyslipidaemia in HIV infected adult Zimbabweans. Open AIDS J, 10, 190–198.
32.
MasemolaML, AlbertsM, and UrdalP. (2007). Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population. Scand J Public Health Suppl, 69, 60–65.
33.
MehriS, BaudinB, MahjoubS, et al. (2010). Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population. Genet Test Mol Biomarkers, 14, 85–91.
34.
MorjaneI, KefiR, CharouteH, et al. (2017). Association study of HNF1A polymorphisms with metabolic syndrome in the Moroccan population. Diabetes Metab Syndr, 11Suppl 2, S853–S857.
35.
NoubiapJJ, BignaJJ, NansseuJR, et al. (2018). Prevalence of dyslipidaemia among adults in Africa: A systematic review and meta-analysis. Lancet Glob Health, 6, e998–e1007.
36.
PerticoneF, CeravoloR, CoscoC, et al. (1997). Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients. J Am Coll Cardiol, 29, 365–369.
37.
PetersBJ, PettH, KlungelOH, et al. (2011). Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI. Atherosclerosis, 217, 458–464.
38.
PontremoliR, RaveraM, ViazziF, et al. (2000). Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension. Kidney Int, 57, 561–569.
39.
ReshetnikovEA, AkulovaLY, DobrodomovaIS, DvornykVY, PolonikovAV, and ChurnosovMI. (2015). The insertion-deletion polymorphism of the ACE gene is associated with increased blood pressure in women at the end of pregnancy. J Renin Angiotensin Aldosterone Syst, 16, 623–632.
40.
RigatB, HubertC, Alhenc-GelasF, CambienF, and CorvolP. (1990). An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest, 86, 1343–1346.
41.
RipJ, NiermanMC, WarehamNJ, et al. (2006). Serum lipoprotein lipase concentration and risk for future coronary artery disease: The EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol, 26, 637–642.
42.
SediriY, KallelA, FekiM, et al. (2011). Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population. Eur J Intern Med, 22, 407–411.
43.
SellamiN, LamineLB, TurkiA, et al. (2018). Association of VEGFA variants with altered VEGF secretion and type 2 diabetes: A case-control study. Cytokine, 106, 29–34.
44.
SparkesRS, ZollmanS, KlisakI, et al. (1987). Human genes involved in lipolysis of plasma lipoproteins: Mapping of loci for lipoprotein lipase to 8p22 andhepatic lipase to 15q21. Genomics, 1, 138–144.
45.
StaessenJA, WangJG, GinocchioG, et al. (1997). The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens, 15, 1579–1592.
46.
SteemburgoT, AzevedoMJ, GrossJL, MilagroFI, CampiónJ, and MartínezJA. (2013). The rs9939609 polymorphism in the FTO gene is associated with fat and fiber intakes in patients with type 2 diabetes. J Nutrigenet Nutrigenomics, 6, 97–106.
47.
StoneNJ, RobinsonJG, LichtensteinAH, et al. (2014). 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Circulation. 129, S1–S45.
48.
Vaisi-RayganiA, GhaneialvarH, RahimiZ, et al. (2010). The angiotensin-converting enzyme D allele is an independent risk factor for early onset coronary artery disease. Clin Biochem, 43, 1189–1194.
49.
Vilela-MartinJF, Vaz-de-MeloRO, Cosenso-MartinLN, et al. (2013). Renin angiotensin system blockage associates with insertion/deletion polymorphism of angiotensin-converting enzyme in patients with hypertensive emergency. DNA Cell Biol, 32, 1–8.
50.
WeissLA, PanL, AbneyM, and OberC. (2006). The sex-specific genetic architecture of quantitative traits in humans. Nat Genet, 38, 218–222.
51.
WHO. (2014). Global status report on noncommunicable diseases 2014. Geneva: World Health Organization.
52.
YilmazH, IsbirT, AgachanB, and KaraaliZE. (2005). Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients. Cell Biochem Funct, 23, 23–28.
53.
ZintzarasE, RamanG, KitsiosG, and LauJ. (2008). Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: A meta-analysis. Arch Intern Med, 168, 1077–1089.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
